Skip to main content

HEALTH

Walmart inks deal with Lilly to offer pharmacy patients Humulin
INDIANAPOLIS The nation's largest retailer has teamed up with a drug company to provide an affordable insulin option for people with diabetes.

Lilly's Humulin will be offered by mid-September to Walmart pharmacy patients under the dual-branded name Humulin ReliOn, including 10 mL vials of Humulin R U-100, Humulin N and Humulin 70/30 formulations.
Weak economy, pharmacy margin woes dampen Walgreens’ sales, hit earnings

Bristol-Myers Squibb, AstraZeneca: Dapagliflozin meets trial endpoints
Roche implements risk-mitigation plan for taspoglutide
Public interest group welcomes regulation of direct-to-consumer genetic tests
NCPA offers solutions to pharmaceutical waste in long-term care dispensing
Drug maker targeted in press release hoax
A1c readings may not be accurate for some ethnic groups, study finds

NEW YORK The hemoglobin A1c test may not provide accurate results for elderly Asians, according to published reports about a new study.

The American Diabetes Association said the test works when doctors use an A1c reading of 6.5% to indicate diabetes, but the study, conducted in Singapore, found that the cutoff often misses the disease in older Asians. The study was conducted on participants between the ages of 20 and 93 years.
Survey: Consumers want self-service to manage healthcare expenses
Finesse launches line for aging hair

X

This ad will auto-close in 10 seconds